You are here

Complement to the call of Extraordinary General Shareholders' Meeting of Bioiberica S.A.

16 Jun 2016
Bioiberica

Called for 4 July 2016

The Board of Directors of BIOIBÉRICA, S.A. (Bioibérica or the Company), in accordance with article 172 of the Capital Companies Act (Real Decreto Legislativo 1/2010, de 2 de Julio, por el que se aprueba el texto refundido de la Ley de Sociedades de Capital) (Capital Companies Act) and following the request from the shareholder Visión Global, S.L., publishes this complement to the announcement of the General Shareholders’ Meeting of the Company called for 4 July 2016 published in the Company’s website on 2 June 2016.

Point 4 in the agenda changes to point 6 and two additional points are added to the agenda of the referred General Shareholders’ Meeting of Bioibérica:


Fourth.- Information to the General Shareholders’ Meeting in relation to the intra-group transactions carried out by the Company, actions taken by the former CEO and the Board and new measures to be taken, if any


Fifth.- Potential liability actions to be taken against all or some of the directors

Therefore, the full agenda shall be as follows:


First.- Changes in the organisational structure of the Board of Directors and revocation of the General Shareholders meeting resolution adopted on 17 December 2015 regarding the distribution of Board positions


Second.- Removal of Mr Jose Escaich as director of the Company


Third.- Appointment of a new director of the Company


Fourth.- Information to the General Shareholders’ Meeting in relation to the intra-group transactions carried out by the Company, actions taken by the former CEO and the Board and new measures to be taken, if any


Fifth.- Potential liability actions to be taken against all or some of the directors


Sixth.- Drafting, reading and approval of the minutes of the meeting

The Board of Directors has agreed to request the presence of a Notary to take the minutes of the General Shareholders’ Meeting, in accordance with the provisions of article 203 of the Capital Companies Act, with respect to article 101 of the Company Register Regulation (Real Decreto 1784/1996, de 19 de Julio, por el que se aprueba el Reglamento del Registro Mercantil). 

The Board of Directors has agreed also to hold the Extraordinary General Shareholders’ Meeting in the corporate domicile of the Company, at Ctra. Nacional II, km. 688, Zona Industrial, Palafolls, Barcelona. 

This complement to the call of the Extraordinary General Shareholders’ Meeting will be published in the website of the Company within the period legally established. 

Mr Kurt Stoffel (Chairman)

Related News

23 Jan 2024
Bioiberica

On a planet where natural resources are limited and there is increasing concern for the environment, the circular economy has emerged as an innovative and sustainable solution.

16 Oct 2023
Bioiberica

We participated in CPHI 2023 in Barcelona, ​​where we showcased our leadership in scientific research, sustainable development and strategic partnerships for a more resilient future with our portfolio of Active Pharmaceutical and Nutraceutical Ingredients.

Bioiberica